In vitro activities of five new antimicrobial agents against Brucella melitensis

We measured the in vitro activity of five new antimicrobial agents that were kindly provided by their respective manufacturers: quinupristin/dalfopristin, linezolid, eperezolid and rifabutin and mupirocin, doxycycline and compared them with the activity of established antimicrobials (streptomycin, d...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of antimicrobial agents Vol. 12; no. 2; pp. 185 - 186
Main Authors:	Trujillano-Martı́n, Ignacio, Garcı́a-Sánchez, Enrique, Fresnadillo, Marı́a José, Garcı́a-Sánchez, José Elı́as, Garcı́a-Rodrı́guez, José Ángel, Montes Martı́nez, Isaı́as
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier B.V 01-07-1999
Subjects:	Acetamides - pharmacology Anti-Bacterial Agents - pharmacology Brucella melitensis Brucella melitensis - drug effects Humans Linezolid Microbial Sensitivity Tests Mupirocin - pharmacology Oxazoles - pharmacology Oxazolidinones Rifabutin - pharmacology Virginiamycin - analogs & derivatives Virginiamycin - pharmacology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	We measured the in vitro activity of five new antimicrobial agents that were kindly provided by their respective manufacturers: quinupristin/dalfopristin, linezolid, eperezolid and rifabutin and mupirocin, doxycycline and compared them with the activity of established antimicrobials (streptomycin, doxycycline and rifampicin) against 105 strains of Brucella melitensis, including the type strain B. melitensis ATCC 23456.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1
ISSN:	0924-8579 1872-7913
DOI:	10.1016/S0924-8579(99)00049-7